BeStock  
Markets › Compare › HROW vs TEVA

HROW vs TEVA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
HROW · Harrow$30.41 ▼ 5.35%
TEVA · Teva Pharmaceutical Industries$39.23 ▲ 1.79%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6092123155186Nov 24, '25May 26, '26Nov 20, '26
  • HROW -22.0%
  • TEVA +58.4%

Head to head

MetricHROWTEVA
Price$30.41$39.23
Change today▼ 5.35%▲ 1.79%
Market cap$1.14B$45.77B
Return, 3 months-23.6%+6.2%
Return, year to date-37.9%+25.7%
Return, 1 year-21.8%+62.0%
P/E (TTM)–91.2
P/B39.15.7
P/E percentile vs own 5y38th99th
Dividend yield––
Revenue growth (YoY, latest qtr)+38.6%-1.9%
Net profit growth (YoY)+856.6%-46.1%
Gross margin73.5%53.5%
Operating margin-2.0%19.2%
Net margin-9.4%2.9%
Return on equity-74.8%6.6%
Analyst target vs. price+109.4%+31.4%
Analyst buy share100%100%
RSI (14)5340
30-day volatility67.6%38.6%
Max drawdown, 1 year-52.5%-21.8%
Trend readLeaning bullishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TEVA is the largest of the group by market value.
  • TEVA has returned the most over the past year.
  • HROW is growing revenue fastest.
  • TEVA keeps the most profit per dollar of sales.
  • TEVA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top